Professor Khoo leads a research programme in Infection Pharmacology and has a focus on HIV, SARS-CoV-2 and tuberculosis infections, and carries out clinical trials ranging from first-into-human evaluations through to post-registrational studies. Professor Khoo also leads the Liverpool Drug Interactions Programmes for HIV, hepatitis and Covid-19 (
www.drug-interactions.org), returning over 11 million searches from 220 countries in 2022, supporting national and international treatment guidelines. He also runs the Liverpool Bioanalytical Facility - a GCP accredited laboratory for drug measurement by LC-MS, undertaking highly sensitive measurements in plasma, body fluids, cells and tissues to inform our research into perinatal pharmacology, mucosal drug accumulation for HIV prevention, and trials of agents used for treating COVID-19, HIV, TB and snakebite.